Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
PatentUS20230278991A1
Safety Considerations and Common Side Effects As with any medication, Empagliflozin comes with potential risks
The body does not exclusively target fat stores during periods of severe energy restriction
If this is your first injection, your dose will be 0.25mg
This impending patent cliff is a material headwind for Novo Nordisk, but price reductions will drive a substantial uplift in the volume of patients on injectable semaglutide, through preferential reimbursement (by state or PMI payors) and improved affordability for the self-pay segment
US$ 24.75
US$ 27.81
US$ 28.13
US$ 27.29
US$ 24.38
